ReviewIJID regions2025
Addressing key risk factors hindering tuberculosis control activities in West Africa - progress in meeting the UN sustainable development goals.
Review in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Novel Clinical Nomogram for Predicting Unfavorable Tuberculosis Treatment Outcomes: A Logistic Regression Risk Model.Journal of epidemiology and global health · 2026Article
- Tuberculosis: An Ongoing Global Threat.Advances in experimental medicine and biology · 2026Review
- Tuberculosis: An Ongoing Global Threat.Advances in experimental medicine and biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) remains a significant public health challenge in West Africa, exacerbated by factors such as HIV, malnutrition, non-communicable diseases, drug-resistant TB, and under-resourced health systems. Addressing these challenges is essential to achieving the World Health Organization's End TB Strategy and Universal Health Coverage goals. This paper explores key strategies for tackling TB and its associated risks in the region. Malnutrition, non-communicable diseases such as hypertension, chronic respiratory diseases, and substance abuse amplify TB burdens. Health system strengthening is pivotal for early TB detection and management. Expanding diagnostic capabilities, particularly through the GeneXpert MTB/RIF assay and Hub-and-Spoke models, alongside workforce development and retention, is crucial. Regional collaborations such as the West African Network of Excellence for Tuberculosis, AIDS, and Malaria (WANETAM) and the Pan-Africa Network for Genomic Surveillance of Poverty-Related Diseases and Emerging Pathogens (PANGenS) demonstrate the importance of collective efforts in research and genomic surveillance. Our article highlights the importance of integrated healthcare approaches, regional partnerships, and community engagement in reducing TB prevalence and improving outcomes. These strategies will not only combat TB but also address its social determinants, advancing health equity in West Africa. By adopting these measures, the region can make significant strides toward UN TB SDG goals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.